Literature DB >> 18342903

Immunochemical and proteomic technologies as tools for unravelling toxins involved in envenoming by accidental contact with Lonomia obliqua caterpillars.

Maria Esther Ricci-Silva1, Richard Hemmi Valente, Ileana Rodriguez León, Denise Vilarinho Tambourgi, Oscar Henrique Pereira Ramos, Jonas Perales, Ana Marisa Chudzinski-Tavassi.   

Abstract

The accidental contact with Lonomia obliqua caterpillar causes local and systemic symptoms (such as fibrinogen depletion), leading, in some cases, to serious clinical complications (acute renal failure and intracranial haemorrhage). Fortunately, a successful therapeutical approach using anti-Lonomic serum, produced in horses against L. obliqua's bristle extract, has already been put in place. However, a global view of immunogenic toxins involved in the coagulation disorders could help to elucidate the envenoming process. In the present study, our aim was to identify bristle extract's immunogenic components, especially those related to the haemostasis, coupling proteomics and immunochemical approaches (bidimensional electrophoresis, mass spectrometry and immunoblotting). The bidimensional map of bristle extract showed a broad profile of 157 silver-stained spots, where at least 153 spots were immunochemically revealed. Twenty-four of these spots were submitted to sequencing by mass spectrometry and three different categories of proteins were identified: lipocalins, cuticle proteins and serpins. From these protein families, it was observed that the most abundant was the lipocalin family, specifically represented by different isoforms of Lopap (a prothrombin activator protein), reinforcing its relevance during envenoming. Peptide sequences of several other immunochemically revealed spots showed no correspondence to any known sequence and were classified as unknown proteins. These proteins could represent new immunogenic molecules and/or toxins. The sequences presented in this article can be used for oligonucleotide design aiming the amplification of cDNAs coding for new molecules using L. obliqua bristles' cDNA libraries or isolated RNAs as template.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18342903     DOI: 10.1016/j.toxicon.2008.01.013

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  5 in total

1.  Mechanisms of acute kidney injury induced by experimental Lonomia obliqua envenomation.

Authors:  Markus Berger; Lucélia Santi; Walter O Beys-da-Silva; Fabrício Marcus Silva Oliveira; Marcelo Vidigal Caliari; John R Yates; Maria Aparecida Ribeiro Vieira; Jorge Almeida Guimarães
Journal:  Arch Toxicol       Date:  2014-05-06       Impact factor: 5.153

2.  A lipocalin-derived Peptide modulating fibroblasts and extracellular matrix proteins.

Authors:  Linda Christian Carrijo-Carvalho; Durvanei A Maria; Janaina S Ventura; Kátia L P Morais; Robson L Melo; Consuelo Junqueira Rodrigues; Ana Marisa Chudzinski-Tavassi
Journal:  J Toxicol       Date:  2012-04-26

3.  Effects of Lonomia obliqua Venom on Vascular Smooth Muscle Cells: Contribution of NADPH Oxidase-Derived Reactive Oxygen Species.

Authors:  João Alfredo Moraes; Genilson Rodrigues; Vany Nascimento-Silva; Mariana Renovato-Martins; Markus Berger; Jorge Almeida Guimarães; Christina Barja-Fidalgo
Journal:  Toxins (Basel)       Date:  2017-11-07       Impact factor: 4.546

Review 4.  Lonomia obliqua Envenoming and Innovative Research.

Authors:  Miryam Paola Alvarez-Flores; Renata Nascimento Gomes; Dilza Trevisan-Silva; Douglas Souza Oliveira; Isabel de Fátima Correia Batista; Marcus Vinicius Buri; Angela Maria Alvarez; Carlos DeOcesano-Pereira; Marcelo Medina de Souza; Ana Marisa Chudzinski-Tavassi
Journal:  Toxins (Basel)       Date:  2021-11-23       Impact factor: 4.546

5.  Effect of Lonomia obliqua Venom on Human Neutrophils.

Authors:  João Alfredo Moraes; Genilson Rodrigues; Daniel Guimarães-Bastos; Vany Nascimento-Silva; Erik Svensjö; Mariana Renovato-Martins; Markus Berger; Jorge Guimarães; Christina Barja-Fidalgo
Journal:  Toxins (Basel)       Date:  2021-12-18       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.